These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9297267

  • 1. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI, Bagriĭ AE, Lebed' IA, Iarovaia NF, Shchukina EV, Gaĭdukov VO, Gritsenko PV, Diadyk IA.
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 3. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 Jan; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 4. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI, Bagriy AE, Lebed IA, Yarovaya NF, Schukina EV, Taradin GG.
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [Abstract] [Full Text] [Related]

  • 5. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P, Roudaut R, Herrero G, Dallocchio M.
    J Cardiovasc Pharmacol; 1990 May; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [Abstract] [Full Text] [Related]

  • 6. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994 May; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E, Gaudreau M, Lachance D, Drolet MC, Roussel E, Gauthier C, Lapointe E, Arsenault M, Couet J.
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
    Maia LN, Nicolau JC, Vítola JV, Santos M, Brandi JM, Joaquim MR, Baggi JM, Cordeiro JA, de Godoy MF.
    Am Heart J; 2003 Jun; 145(6):E21. PubMed ID: 12796769
    [Abstract] [Full Text] [Related]

  • 13. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I, Pechánová O, Pelouch V, Simko F.
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [Abstract] [Full Text] [Related]

  • 14. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA.
    Circulation; 2005 Jun 28; 111(25):3411-9. PubMed ID: 15967846
    [Abstract] [Full Text] [Related]

  • 15. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Paoletti E, Cassottana P, Amidone M, Gherzi M, Rolla D, Cannella G.
    Am J Kidney Dis; 2007 Jul 28; 50(1):133-42. PubMed ID: 17591533
    [Abstract] [Full Text] [Related]

  • 16. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC, El Aouar LM, Mill JG.
    Arq Bras Cardiol; 2000 Feb 28; 74(2):103-17. PubMed ID: 10904284
    [Abstract] [Full Text] [Related]

  • 17. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 28; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 18. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B, Vajo Z, Dachman W.
    Acta Physiol Hung; 1996 Dec 28; 84(4):361-7. PubMed ID: 9328608
    [Abstract] [Full Text] [Related]

  • 19. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
    Kamper AL, Strandgaard S, Leyssac PP.
    Ugeskr Laeger; 1993 Aug 02; 155(31):2406-9. PubMed ID: 8346593
    [Abstract] [Full Text] [Related]

  • 20. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E, Minetti EE, Cozzi MG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 02; 3(1):40-5. PubMed ID: 11984747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.